| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $321.0M | +40.0% |
| Cost of Revenue | $207.0M | +36.5% |
| R&D Expense | $691K | — |
| SG&A Expense | $45.2M | +65.8% |
| Operating Income | $34.5M | +80.3% |
| Interest Expense | $29.2M | +14.6% |
| Pre-tax Income | $5.3M | +179.3% |
| Income Tax | $524K | +75.8% |
| Net Income | $1.7M | +124.3% |
| EPS (Basic) | $0.04 | -20.0% |
| EPS (Diluted) | $0.04 | -20.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -98.1% |
| Accounts Receivable | $81.7M | +94.6% |
| Current Assets | $139.0M | +5.0% |
| Total Assets | $1.30B | +15.7% |
| Current Liabilities | $91.4M | +86.4% |
| Long-term Debt | $428.9M | +9.4% |
| Total Liabilities | $646.3M | +23.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $70.2M | +19.4% |
| Capital Expenditures | $146.5M | +96.2% |
| Investing Cash Flow | -$136.9M | -83.4% |
| Financing Cash Flow | $7.8M | -84.7% |
| Free Cash Flow | -$76.3M | -381.4% |
| Stockholders' Equity |
| $309.5M |
| +45.4% |